Biotech

All Articles

Orion to make use of Aitia's 'electronic twins' to discover brand new cancer cells medicines

.Finnish biotech Orion has actually spied possible in Aitia's "electronic identical twin" specialist...

Windtree's surprise med rears blood pressure in most current phase 2 win

.While Windtree Therapeutics has actually struggled to develop the economic roots needed to have to ...

2 cancer biotechs merge, developing global footprint

.OncoC4 is taking AcroImmune-- and also its own internal clinical production capacities-- under its ...

Amgen files first phase 3 win for $400M dermatitis drug

.Amgen has actually discussed (PDF) the first phase 3 data on its $400 million dermatitis drug, link...

Biogen, UCB report stage 3 lupus gain after stopping working earlier test

.Biogen and UCB's depend improving in to phase 3 on the back of a failed research study aims to have...

Aptadir hopes brand new RNA preventions can turn around challenging cancers

.Italian biotech Aptadir Rehabs has actually launched with the guarantee that its own pipe of precli...

Wave surfs DMD results to regulatory authorities' doors, sending stock up

.Surge Lifestyle Sciences has actually satisfied its own objective in a Duchenne muscle dystrophy (D...

Sanofi plucks brand-new CSO from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma crease, using...

Achilles splashes cell therapy program, prepares for discharges after missing out on 'business practicality' goals

.Achilles Therapeutics has torn up its approach. The English biotech is stopping work on its clinica...

Aligos declares stage 2 MASH win, reducing liver excess fat up to 46%

.Aligos Therapies is actually proclaiming a midstage win in metabolic-dysfunction associated steatoh...